Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ranger Investment Management L.P. increased its position in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 0.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 198,476 shares of the health services provider’s stock after purchasing an additional 1,155 shares during the period. […]
Principal Financial Group Inc. cut its holdings in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 0.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 119,771 shares of the health services provider’s stock after selling 563 shares during the quarter. Principal Financial Group […]
StockNews.com upgraded shares of Amedisys (NASDAQ:AMED – Free Report) from a hold rating to a buy rating in a report published on Saturday morning. A number of other equities research analysts have also weighed in on the stock. Cantor Fitzgerald reiterated a neutral rating and set a $101.00 target price on shares of Amedisys in […]
StockNews.com upgraded shares of Amedisys (NASDAQ:AMED – Free Report) from a hold rating to a buy rating in a report released on Saturday morning. A number of other brokerages also recently issued reports on AMED. Cantor Fitzgerald reiterated a neutral rating and set a $101.00 price target on shares of Amedisys in a research report […]
Cantor Fitzgerald restated their neutral rating on shares of Amedisys (NASDAQ:AMED – Free Report) in a report released on Thursday morning, Benzinga reports. The firm currently has a $101.00 price objective on the health services provider’s stock. Several other equities research analysts have also commented on the stock. StockNews.com started coverage on shares of Amedisys […]